Selected article for: "case patient and clinical recovery"
Author: Ahmad, Faran; Ahmed, Arslan; Rajendraprasad, Sanu S.; Loranger, Austin; Gupta, Sonia; Velagapudi, Manasa; Vivekanandan, Renuga; Nahas, Joseph A.; Plambeck, Robert; Moore, Douglas
Title: Multisystem Inflammatory Syndrome in Adults: A Rare Sequela of SARS-CoV-2 Infection
  • Cord-id: z3c8e7wy
  • Document date: 2021_5_24
    • ID: z3c8e7wy
    Snippet: The multisystem inflammatory syndrome in adults (MIS-A) came to attention back in June 2020, when the United States Center for Disease Control and Prevention (CDC) got initial reports regarding the patients who had delayed and multisystem involvement of the disease with clinical course resembling the multisystem inflammatory syndrome in children (MIS-C). We share a case of MIS-A, where the patient presented three weeks after the initial COVID19 exposure. His clinical course was consistent with t
    Document: The multisystem inflammatory syndrome in adults (MIS-A) came to attention back in June 2020, when the United States Center for Disease Control and Prevention (CDC) got initial reports regarding the patients who had delayed and multisystem involvement of the disease with clinical course resembling the multisystem inflammatory syndrome in children (MIS-C). We share a case of MIS-A, where the patient presented three weeks after the initial COVID19 exposure. His clinical course was consistent with the working definition of MIS-A as specified by CDC. Aggressive supportive care in the intensive care unit, utilization of advanced heart failure devices, and immunomodulatory therapeutics (high dose steroids, anakinra, intravenous immunoglobulin) led to clinical recovery. Management of MIS-A is a topic of ongoing research and needs more studies to elaborate on the treatment modalities and clinical predictors.

    Search related documents:
    Co phrase search for related documents
    • action mechanism and additional therapy: 1
    • action mechanism and adjunctive therapy: 1, 2
    • action mechanism and lung clear: 1
    • additional therapy and adjunctive therapy: 1, 2